Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions

Schizophrenia, which affects around 1% of the world’s population, has been described as a complex set of symptoms triggered by multiple factors. However, the exact background mechanisms remain to be explored, whereas therapeutic agents with excellent effectivity and safety profiles have yet to...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kekesi, Szabolcs Dvorácskó, Edina Szűcs, Csaba Tömböly, Gyongyi Horvath, Sándor Benyhe, László Vécsei
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2019-10-01
Series:	Molecules
Assuntos:	cannabinoids endocannabinoids cannabinoid receptors kynurenines kynurenine pathway schizophrenia
Acceso en liña:	https://www.mdpi.com/1420-3049/24/20/3709
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!